# QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.

> **NCT05287139** · — · UNKNOWN · sponsor: **Beneficência Portuguesa de São Paulo** · enrollment: 202 (estimated)

## Conditions studied

- Quality of Life
- Breast Neoplasm Female

## Interventions

- **OTHER:** Quality of Life

## Key facts

- **NCT ID:** NCT05287139
- **Lead sponsor:** Beneficência Portuguesa de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-14
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287139, "QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05287139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*